{"id":"W2149584982","doi":"10.1093/annonc/mdu574","title":"A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Cetuximab; Medicine; Internal medicine; Oncology; Clinical endpoint; Tolerability; Phases of clinical research; Head and neck cancer; Cancer; Mucositis; Randomized controlled trial; Chemotherapy; Colorectal cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006987734,0.0002980792,0.001165315,0.0001199988,0.00006197037,0.000009543102,0.0002023322,0.0002000078,0.00004898303],"category_scores_gemma":[0.000216997,0.0001953089,0.00008390668,0.0002098801,0.0004080521,0.00002506365,0.00008097781,0.0001546432,4.610859e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002812203,"about_ca_system_score_gemma":0.0007466075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006039024,"about_ca_topic_score_gemma":0.001697959,"domain_scores_codex":[0.9977482,0.00050334,0.0006206229,0.0005007684,0.0002543458,0.0003727385],"domain_scores_gemma":[0.9983521,0.0001602609,0.0006165213,0.0003725308,0.0003475344,0.0001510158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.976041,0.004873699,0.004183586,0.0001459891,0.0001719585,0.00001331222,0.000381103,0.0001758556,0.006484864,0.000007643132,0.000598372,0.006922614],"study_design_scores_gemma":[0.7675705,0.1040601,0.0001132188,0.00009796418,0.0002206351,0.00000437142,0.00006525806,0.0002338202,0.1241155,0.00001801864,0.003205416,0.0002952427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974771,0.0004662797,0.0001478066,0.0001295394,0.0001765621,0.001366904,0.00006233217,0.00000841037,0.0001650452],"genre_scores_gemma":[0.9962864,0.0001292288,0.002615849,0.0003946931,0.00009527935,0.0001736681,0.0000719551,0.00004071501,0.0001922399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2084705,"threshold_uncertainty_score":0.7964467,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03697488395085397,"score_gpt":0.3559445261094128,"score_spread":0.3189696421585588,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}